Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease (URGE-PD)
-
- STATUS
- Not Recruiting
-
- participants needed
- 23
-
- sponsor
- University of South Florida
Updated on 22 July 2024
Summary
This study will assess the effectiveness of solifenacin succinate (VESIcare) in reducing symptoms of overactive bladder in Parkinson's disease (PD) patients.
Details
| Condition | Overactive Bladder in Parkinson's Disease |
|---|---|
| Age | 40years - 80years |
| Treatment | Placebo, solifenacin succinate (VESIcare) |
| Clinical Study Identifier | NCT01018264 |
| Sponsor | University of South Florida |
| Last Modified on | 22 July 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.